title: A bioassay for topical and systemic effect of three inhaled corticosteroids.
abstract: BACKGROUND
  Comparisons of relative potency for the three inhaled corticosteroids in the United States are limited to assessment of skin blanching.
  
  
  OBJECTIVE
  Development of a method for comparing relative potencies of inhaled corticosteroids for topical effect on human airway and systemic effect.
  
  
  METHODS
  With use of partial suppression of immediate response to inhaled allergen and 24-hour urinary free cortisol output, three-point dose-response curves were constructed for beclomethasone dipropionate (50 micrograms/puff), triamcinolone acetonide (100 micrograms/puff), and flunisolide (250 micrograms/puff). A randomized, parallel, single-blind study design was used. Dosing began with one puff four times a day for flunisolide and two puffs four times a day for the others. Doses were doubled after 1 week and again after a second week.
  
  
  RESULTS
  Twenty-five patients completed the study. Dose-response relationships were shown for each inhaled corticosteroid for both topical and systemic effect. Dose-response curves for the three preparations were similar when response was plotted against delivered dose in micrograms.
  
  
  CONCLUSIONS
  Within the limits of the assays, relative potencies of the three preparations appeared to be approximately equivalent for both topical and systemic effect when dose was expressed in micrograms. Relative potency per puff is therefore approximately proportional to the dose delivered. This method has potential for evaluation of relative potency of newer inhaled corticosteroids and the relative advantage of alternative delivery systems.
authors.affiliation: Pediatric Allergy and Pulmonary Division, College of Medicine, University of Iowa, USA.
authors.forename: M M
authors.initials: MM
authors.lastname: McCubbin
authors.forename: G
authors.initials: G
authors.lastname: Milavetz
authors.forename: S
authors.initials: S
authors.lastname: Grandgeorge
authors.forename: M
authors.initials: M
authors.lastname: Weinberger
authors.forename: R
authors.initials: R
authors.lastname: Ahrens
authors.forename: C
authors.initials: C
authors.lastname: Sargent
authors.forename: L M
authors.initials: LM
authors.lastname: Vaughan
mesh_terms: D000280:Administration, Inhalation; D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001249:Asthma / Q000188:drug therapy*; D001507:Beclomethasone / Q000008:administration & dosage / Q000494:pharmacology*; D001681:Biological Assay; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005446:Fluocinolone Acetonide / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D008297:Male; D016037:Single-Blind Method; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D000893:Anti-Inflammatory Agents; D005446:Fluocinolone Acetonide; C007734:flunisolide; D014222:Triamcinolone Acetonide; D001507:Beclomethasone